beta

ZIOP

Ziopharm Oncology, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap: 624 Million

Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)

Website:

Shares Outstanding: 214 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.2747810296183089

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 2753 trading days

From: 2015-11-10 To: 2020-11-27

Lowest Point:

Ziopharm up 3% on FDA sign-off on study involving Sleeping Beauty platform

via: SeekingAlpha at 2019-06-11 08:06:22:000

Ziopharm Oncology ( ZIOP +3.3% ) perks up on average volume in reaction to its announcement that the FDA has signed off on a National Cancer Institute-sponsored study evaluating T-cell receptor (TCR)T-cell therapy using the company's Sleeping Beauty platform for the treatment of … read more...

Ziopharm up 3% on FDA sign-off on study involving Sleeping Beauty platform

via: SeekingAlpha at 2019-06-11 08:06:22:000

Ziopharm Oncology ( ZIOP +3.3% ) perks up on average volume in reaction to its announcement that the FDA has signed off on a National Cancer Institute-sponsored study evaluating T-cell receptor (TCR)T-cell therapy using the company's Sleeping Beauty platform for the treatment of … read more...

Ziopharm up 3% on FDA sign-off on study involving Sleeping Beauty platform

via: SeekingAlpha at 2019-06-11 08:06:22:000

Ziopharm Oncology ( ZIOP +3.3% ) perks up on average volume in reaction to its announcement that the FDA has signed off on a National Cancer Institute-sponsored study evaluating T-cell receptor (TCR)T-cell therapy using the company's Sleeping Beauty platform for the treatment of … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud